术前患者报告结局指标阈值不应用于指示全膝关节置换术
该回顾性研究分析25246例连续初次全膝关节置换术患者,以术前膝关节损伤与骨关节炎结局评分关节置换版40、50、60、70分作为理论阈值,评估低于阈值(获批手术)与高于阈值(拒绝手术)患者的结果。结果显示各阈值下被拒患者1年最小临床重要差异达标率为88.3%至77%,获批患者达标率更高(P<.001)但非家庭出院率更高,两组住院并发症和90天再入院率相似。结论认为设定术前患者报告结局指标阈值可优化患者改善,但可能为部分本可获益患者制造就医障碍。
要点
- 各理论阈值下被拒手术患者1年最小临床重要差异达标率为88.3%、85.9%、79.6%和77%。
- 获批患者最小临床重要差异达标率在所有阈值均更高(P<.001),但非家庭出院率在阈值40、50、60更高(P<.001、P=.002、P=.024)。
- 获批与被拒患者住院并发症率和90天再入院率相似。
核心结论
- 大多数患者在全部理论患者报告结局指标阈值下均达到最小临床重要差异,且并发症和再入院率低。
- 设定术前患者报告结局指标阈值用于全膝关节置换术资格可帮助优化患者改善,但此类政策可能为部分本可获益患者制造就医障碍。
研究设计与样本
- 回顾性分析2016年至2019年25246例连续初次全膝关节置换术患者。
- 采用假设的术前膝关节损伤与骨关节炎结局评分关节置换版切点40、50、60和70分。
- 术前评分低于各阈值视为「获批」手术,高于各阈值视为「拒绝」手术。
- 评估住院并发症、90天再入院和出院去向,并使用先前验证的锚定法计算1年最小临床重要差异达标情况。
主要发现
- 低于阈值40、50、60和70分的「被拒」患者1年最小临床重要差异达标率分别为88.3%、85.9%、79.6%和77%。
- 获批患者住院并发症率分别为2.2%、2.3%、2.1%和2.1%,90天再入院率分别为4.6%、4.5%、4.3%和4.3%。
- 获批患者在所有阈值下最小临床重要差异达标率更高(P<.001),但非家庭出院率在阈值40(P<.001)、50(P=.002)和60(P=.024)高于被拒患者。
- 获批与被拒患者住院并发症率和90天再入院率相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While Medicare requires patient-reported outcome measures (PROMs) for many quality programs, some commercial insurers are requiring preoperative PROMs when determining eligibility for total knee arthroplasty (TKA). Concerns exist that these data may be used to deny TKA to patients above a specific PROM score, but the optimal threshold is unknown. We aimed to evaluate TKA outcomes based on theoretical PROM thresholds. METHODS: We retrospectively analyzed 25,246 consecutive primary TKA patients from 2016 to 2019. Hypothesized preoperative knee injury and osteoarthritis outcome score for joint replacement cutoffs of 40, 50, 60, and 70 points were used. Preoperative scores below each threshold were considered "approved" surgery. Preoperative scores above each threshold were considered "denied" surgery. In-hospital complications, 90-day readmissions, and discharge disposition were evaluated. One-year minimum clinically important difference (MCID) achievement was calculated using previously validated anchor-based methods. RESULTS: For "denied" patients below thresholds 40, 50, 60, and 70 points, 1-year MCID achievement was 88.3%, 85.9%, 79.6%, and 77%, respectively. In-hospital complication rates for approved patients were 2.2%, 2.3%, 2.1%, and 2.1%, while 90-day readmission rates were 4.6%, 4.5%, 4.3%, and 4.3%, respectively. Approved patients had higher MCID achievement rates (P < .001) for all thresholds but higher nonhome discharge rates than denied patients for thresholds 40 (P < .001), 50 (P = .002), and 60 (P = .024). Approved and denied patients had similar in-hospital complication and 90-day readmission rates. CONCLUSION: Most patients achieved MCID at all theoretical PROMs thresholds with low complication and readmission rates. Setting preoperative PROM thresholds for TKA eligibility can help optimize patient improvement, but such a policy can create access to care barriers for some patients who would otherwise benefit from a TKA.
引用
- Sutton RM, Baker CM, D'Amore T, et al. Preoperative Patient-Reported Outcome Measure Thresholds Should Not be Used for Indicating Total Knee Arthroplasty. J Arthroplasty. 2022. PMID: 37343282. doi:10.1016/j.arth.2022.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。